Author:
Li Yang,Yang Kai-di,Kong De-cai,Li Xiao-meng,Duan Hao-yu,Ye Jun-feng
Abstract
Stroke poses a critical global health challenge, leading to substantial morbidity and mortality. Existing treatments often miss vital timeframes and encounter limitations due to adverse effects, prompting the pursuit of innovative approaches to restore compromised brain function. This review explores the potential of filamentous phages in enhancing stroke recovery. Initially antimicrobial-centric, bacteriophage therapy has evolved into a regenerative solution. We explore the diverse role of filamentous phages in post-stroke neurological restoration, emphasizing their ability to integrate peptides into phage coat proteins, thereby facilitating recovery. Experimental evidence supports their efficacy in alleviating post-stroke complications, immune modulation, and tissue regeneration. However, rigorous clinical validation is essential to address challenges like dosing and administration routes. Additionally, genetic modification enhances their potential as injectable biomaterials for complex brain tissue issues. This review emphasizes innovative strategies and the capacity of filamentous phages to contribute to enhanced stroke recovery, as opposed to serving as standalone treatment, particularly in addressing stroke-induced brain tissue damage.
Reference125 articles.
1. Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019;Feigin;Lancet Neurology,2021
2. Heart disease and stroke statistics-2022 update: A report from the American heart association;Tsao;Circulation,2022
3. Global epidemiology of stroke and access to acute ischemic stroke interventions;Saini;Neurology,2021
4. Neuroinflammation, stroke, blood-brain barrier dysfunction, and imaging modalities;Candelario-Jalil;Stroke,2022
5. Stroke;Hankey;Lancet,2017
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献